Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 159 for Treatment
  1. GHR gene 
    ... that children with these disorders respond differently to treatment depending on which isoform of the growth hormone ... GHR has been associated with faster growth during treatment compared with fl-GHR. Other studies have not ...
    https://medlineplus.gov/genetics/gene/ghr - Genetics
  2. F9 gene 
    ... 9.1517. Citation on PubMed Kristensen SR. Warfarin treatment of a patient with coagulation factor IX propeptide ... Sensitivity. Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and ...
    https://medlineplus.gov/genetics/gene/f9 - Genetics
  3. VKORC1 gene 
    ... process. If people with warfarin resistance require anticoagulant treatment and take the average warfarin dose (or less), ... BF. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. ...
    https://medlineplus.gov/genetics/gene/vkorc1 - Genetics
  4. CREBBP gene 
    ... found in some people who have undergone cancer treatment. This chromosomal change is associated with the later ... and myelodysplastic syndrome). These are sometimes described as treatment-related cancers because the translocation between chromosomes 11 ...
    https://medlineplus.gov/genetics/gene/crebbp - Genetics
  5. RPE65 gene 
    ... the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet. 2009 Jun;30(2):57-62. ... Byrne BJ, Jacobson SG, Hauswirth WW. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle ...
    https://medlineplus.gov/genetics/gene/rpe65 - Genetics
  6. HTT gene 
    ... s disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci. 2006 Nov;63( ... G, Vecsei L. Huntington's disease: pathomechanism and therapeutic perspectives. J Neural Transm (Vienna). 2004 Oct;111( ...
    https://medlineplus.gov/genetics/gene/htt - Genetics
  7. IDS gene 
    ... II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation. Biochim Biophys Acta. ... Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur ...
    https://medlineplus.gov/genetics/gene/ids - Genetics
  8. GNE gene 
    ... MC, Huizing M. GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges. Neurotherapeutics. 2018 Oct;15(4):900-914. ... distal myopathy with rimmed vacuoles (DMRV) or hIBM: treatment perspectives. Curr Opin Neurol. 2008 Oct;21(5): ...
    https://medlineplus.gov/genetics/gene/gne - Genetics
  9. CYP2C9 gene 
    ... BF. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost. 2010 Jan;8(1):95- ... Central van der Zee SA, Halperin JL. Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice. Nat ...
    https://medlineplus.gov/genetics/gene/cyp2c9 - Genetics
  10. HBB gene 
    ... Mello HL, Costa J. Methemoglobinemia: from diagnosis to treatment. Rev Bras Anestesiol. 2008 Nov-Dec;58(6): ... human hematopoietic stem cells as a potential durable treatment for sickle cell disease. Sci Transl Med. 2021 ...
    https://medlineplus.gov/genetics/gene/hbb - Genetics
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next